TFX Stock Recent News
TFX LATEST HEADLINES
Teleflex (TFX) secures the Peripheral Access purchasing agreement with Premier, Inc.
Teleflex stock (NYSE: TFX), which provides instruments and consumables for laboratories, trades at $220 per share, 50% below the level seen in March 2021.
Investors remain optimistic about Teleflex (TFX) on the strength of the Vascular and Interventional businesses.
Teleflex's (TFX) ACCESS-MANTA Registry is likely to examine the contemporary on-label use of the MANTA VCD.
WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 35th Annual Piper Sandler Healthcare Conference at The Lotte New York Palace, New York, NY, on Tuesday, November 28, 2023 at 11:30 a.m. (ET).
Teleflex Incorporated (TFX) Q3 2023 Earnings Call Transcript
Teleflex's (TFX) year-over-year revenue growth was driven by all global product categories in Q3.
Teleflex beat third quarter profit estimates on Thursday as volumes of non-urgent surgical procedures picked up in hospitals post pandemic, lifting demand for its medical devices.
WAYNE, Pa., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Jefferies London Healthcare Conference, on Tuesday, November 14, 2023, at 9:00 a.m. (GMT).
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.